TM6SF2 and metabolic dysfunction-associated steatohepatitis: In contrast, despite the other major FLD risk, variants in TM6SF2 and MBOAT7 were associated with NASH and fibrosis, and there was no significant interaction of these variants with female sex on any feature of liver damage, with a very similar effect size in men and women (Supplementary Table 3).